Skip to Content

Supergen Changes Name to Astex Pharma After Deal

SuperGen changes name to Astex Pharma after deal

From Associated Press (September 12, 2011)


DUBLIN, Calif. -- SuperGen Inc. said Monday it formally changed its name to Astex Pharmaceuticals Inc. following an acquisition.

As part of the name change, the company's ticker symbol changed to "ASTX" from "SUPG." The shares trade on the Nasdaq.

SuperGen announced the name change in April, when it agreed to acquire Astex Therapeutics Ltd. SuperGen makes drugs that fight tumors and blood disorders, and Astex Therapeutics was a British company developing treatments for cancer and viruses.

SuperGen helped develop the bone marrow disease drug Dacogen, which is sold by Johnson & Johnson and Eisai Co. Astex Pharmaceuticals has partnerships with several other large drugmakers, including GlaxoSmithKline PLC and Novartis AG, and it has four drugs that are in mid-stage clinical trials or about to enter those studies.

Astex shares rose 7 cents, or 3.5 percent, to $2.10 in afternoon trading.

Posted: September 2011